Nonclassic adrenal hyperplasia

PW Speiser - Reviews in Endocrine and Metabolic Disorders, 2009 - Springer
Nonclassic adrenal hyperplasia is most commonly attributable to mutations in CYP21A2
(also termed CYP21) encoding steroid 21-hydroxylase. Partial deficiency of this enzyme …

Nonclassic adrenal hyperplasia

PW Speiser - Reviews in Endocrine and Metabolic Disorders, 2009 - infona.pl
Nonclassic adrenal hyperplasia is most commonly attributable to mutations in CYP21A2
(also termed CYP21) encoding steroid 21-hydroxylase. Partial deficiency of this enzyme …

[引用][C] Nonclassic adrenal hyperplasia

PW Speiser - Reviews in Endocrine and Metabolic Disorders, 2008 - cir.nii.ac.jp

Nonclassic adrenal hyperplasia

PW Speiser - Reviews in Endocrine & Metabolic Disorders, 2009 - search.proquest.com
Nonclassic adrenal hyperplasia Page 1 Rev Endocr Metab Disord (2009) 10:77782 DOl
10.1007/s11154—008—9097—x Nonclassic adrenal hyperplasia Phyllis W. Speiser Published …

Nonclassic adrenal hyperplasia.

PW Speiser - Reviews in Endocrine & Metabolic Disorders, 2009 - europepmc.org
Nonclassic adrenal hyperplasia is most commonly attributable to mutations in CYP21A2
(also termed CYP21) encoding steroid 21-hydroxylase. Partial deficiency of this enzyme …

Nonclassic adrenal hyperplasia

PW Speiser - Reviews in endocrine & metabolic disorders, 2009 - pubmed.ncbi.nlm.nih.gov
Nonclassic adrenal hyperplasia is most commonly attributable to mutations in CYP21A2
(also termed CYP21) encoding steroid 21-hydroxylase. Partial deficiency of this enzyme …

[引用][C] Nonclassic adrenal hyperplasia

PW Speiser - Reviews in Endocrine & Metabolic Disorders, 2009 - Springer

[引用][C] Nonclassic adrenal hyperplasia

PW Speiser - Reviews in endocrine and metabolic disorders, 2009 - Springer